Lessons From Taxanes Versus Eribulin for First-Line Metastatic Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the EMERALD Study
Authors: Tess A. O'Meara, Paolo Tarantino
Published: 2025-01-22
DOI:
10.1200/jco-24-02717
Source:
Full article
Abstract
No abstract found.